Aethlon Medical is closely monitoring the Bird Flu situation and stands ready to work alongside hospitals, health agencies and the FDA if existing therapies prove inadequate.
Date | Form | Description | XBRL | Pages |
---|---|---|---|---|
02/18/15 | SC 13D | Form SC 13D: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities | 4 | |
02/10/15 | 8-K | Form 8-K: Current report filing | 3 | |
02/10/15 | 424B3 | Form 424B3: Prospectus filed pursuant to Rule 424(b)(3) | 44 | |
02/10/15 | 10-Q | Form 10-Q: Quarterly report pursuant to Section 13 or 15(d) |
|
47 |
02/02/15 | CT ORDER | Form CT ORDER: Confidential treatment order | 1 | |
01/30/15 | 424B3 | Form 424B3: Prospectus filed pursuant to Rule 424(b)(3) | 169 | |
01/28/15 | EFFECT | Form EFFECT: Notice of Effectiveness | 1 | |
12/31/14 | S-1 | Form S-1: General form of registration statement for all companies including face-amount certificate companies |
|
275 |
12/31/14 | 8-K | Form 8-K: Current report filing | 3 | |
12/16/14 | 8-K | Form 8-K: Current report filing | 5 |